Atrial fibrillation: Occurrence, mechanisms, clinical presentation - Determination of medical status and approach;Vorhofflimmern - Eine standortbestimmung vorkommen, mechanismen und klinische präsentation

Klinikarzt

Volumn 37, Issue 2, 2008, Pages 66-70

  Kirchhof, Paulus ^a   Breithardt, Günter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Anticoagulation; Atrial fibrillation; Clinical presentation; Frequency regulation; Paroxysmal; Permanent; Persistent; Prevalence; Rhythm preservation therapy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ATRIOVENTRICULAR BLOCK; BLOOD CLOTTING; CARDIOVASCULAR RISK; CARDIOVERSION; CATHETER ABLATION; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE SEVERITY; EMBOLISM; EXTRACELLULAR MATRIX; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; LUNG EDEMA; PREVALENCE; REVIEW; STROKE; SYNCOPE; TREATMENT OUTCOME;

EID: 40949106092     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1062692     Document Type: Review

References (36)

1. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54 (2): 230-246
2. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27 (2): 136-149
3. Brugada R, Tapscott T, Czernuszewicz GZ et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336 (13): 905-911
4. Calkins H, Brugada J, Packer DL et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace 2007; 9 (9): 335-379
5. Conway DS, Heeringa J, Van Der Kuip DA et al. Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study. Stroke 2003; 34 (2): 413-417
6. de Haan S, Greiser M, Harks E et al. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation 2006; 114 (12): 1234-1242
7. Dorian P, Paquette M, Newman D et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002; 143 (6): 984-990
8. Eckardt L, Kirchhof P, Loh P et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol 2001; 12 (6): 680-685
9. Fetsch T, Bauer P, Engberding R et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 2004; 25 (16): 1385-1394
10. Fox CS, Parise H, D'Agostino RB Sr et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004; 291 (23): 2851-2855
11. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8 (9): 651-745
12. Giustetto C, Di Monte F, Wolpert C et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006; 27 (20): 2440-2447
13. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285 (18): 2370-2375
14. Hagens VE, Van Veldhuisen DJ, Kamp O et al. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: Results from the RAte Control versus Electrical cardioversion for persistent atrial fibrillation (RACE) study. Heart Rhythm 2005; 2 (1): 19-24
15. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339 (10): 659-666
16. Healey JS, Morillo CA, Connolly SJ. Role of the renin-angiotensin- aldosterone system in atrial fibrillation and cardiac remodeling. Curr Opin Cardiol 2005; 20 (1): 31-37
17. Hsu LF, Jais P, Sanders P et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351 (23): 2373-2383
18. Jenkins LS, Brodsky M, Schron E et al. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005; 149 (1): 112-120
19. Kerr CR, Humphries KH, Talajic M et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005; 149 (3): 489-496
20. Kirchhof P, Auricchio A, Bax J et al. Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007; 28 (22): 2803-2817
21. Kirchhof P, Breithardt G. Behandlung von Vorhofflimmern. Internist (Berl) 2007; 48 (8): 819-829; quiz 830-831
22. Kirchhof P, Eckardt L, Franz MR et al. Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome. J Cardiovasc Electrophysiol 2003; 14 (10): 1027-1033
23. Kirchhof P, Eckardt L, Loh P et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 2002; 360 (9342): 1275-1279
24. Kirchhof P, Fetsch T, Hanrath P et al. Targeted pharmacological reversal of electrical remodeling after cardioversion - rationale and design of the Flecainide Short-Long (Flec-SL) trial. Am Heart J 2005; 150 (5): 899
25. Lip GY, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis. Thromb Res 2006; 118 (3): 321-333
26. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110 (9): 1042-1046
27. Luderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med 2000; 160 (12): 1749-1757
28. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002; 415 (6868): 219-226
29. Nattel S, Opie LH. Controversies in atrial fibrillation. Lancet 2006; 367 (9506): 262-272
30. Patten M, Maas R, Bauer P et al. Suppression of paroxysmal atrial tachyarrhythmias - results of the SOPAT trial. Eur Heart J 2004; 25 (16): 1395-1404
31. Raitt MH, Volgman AS, Zoble RG et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2006; 151 (2): 390-396
32. Rocken C, Peters B, Juenemann G et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002; 106 (16): 2091-2097
33. Singh SN, Tang XC, Singh BN et al. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 2006; 48 (4): 721-730
34. Sulke N, Sayers F, Lip GY. Rhythm control and cardioversion. Heart 2007; 93 (1): 29-34
35. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92 (7): 1954-168
36. Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3 (12): 1445-1452